4d Molecular Therapeutics, Inc. · NASDAQ:FDMT
Goldman Sachs Group Inc reported a 7.50% stake in 4d Molecular Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 9, 2026
Goldman Sachs Group Inc reported a 7.50% stake in 4d Molecular Therapeutics, Inc., 4,286,077 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G/A).
- Stake
- 7.50%
- Shares
- 4,286,077
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 7.50% | 4,286,077 |
| GOLDMAN SACHS & CO. LLC | 7.50% | 4,286,077 |
Source
Related
- 4d Molecular Therapeutics, Inc.
- Goldman Sachs Group Inc
- 4d Molecular Therapeutics, Inc. shareholders
- Schedule 13G/A · Goldman Sachs Group Inc · Feb 10, 2025
- Form 4 · Bizily Scott · Oct 20, 2026
- Form 4 · Kirn David · Oct 7, 2026
- Form 4 · Bizily Scott · Sep 22, 2026
- Form 4 · Kirn David · Sep 16, 2026
- Form 4 · Bizily Scott · Sep 3, 2026